| AVDL Market Cap History Table | ||||||||||||||||||
Below is a table of the AVDL market cap history going back to 2/26/2024:
Also see: AVDL Shares Outstanding History and AVDL YTD Return |
AVDL Market Cap History — Avadel Pharmaceuticals Capitalization Over Time
As of 10/31/2025 Avadel Pharmaceuticals has a market cap of 1.84 billion. Investors often follow the AVDL market cap history to compare the size of the company over time.
This page shows AVDL market capitalization trends over time, with 8 market cap datapoints presented, dating back to 2/26/2024.
| AVDL Market Cap History Chart | ||||||||||||||||||||||||
AVDL Historical Market Cap: +30.76% CAGR 
Mouse over chart for data details
| ||||||||||||||||||||||||
| AVDL Stock Price Chart |
| About Avadel Pharmaceuticals PLC |
| Avadel Pharmaceuticals PLC is a biopharmaceutical company. Co.'s lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and MEDUSA. Its MICROPUMP technology allows for the development of modified release solid, oral dosage formulations of drugs. We show 8 historical shares outstanding datapoints in our AVDL shares outstanding history coverage, used to compute AVDL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AVDL market cap history over the course of time is important for investors interested in comparing AVDL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AVDL versus a peer is one thing; comparing AVDL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AVDL can fluctuate over the course of history. With this page we aim to empower investors researching AVDL by allowing them to research the AVDL market cap history. |
| AVDL Current Stock Quote |
Quotes delayed 20 minutes  Free AVDL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| AVDL Share Performance |
| Market Cap Peers |
| Avadel Pharmaceuticals (AVDL) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AVHI Market Cap History AVPT Market Cap History AXAC Market Cap History AXTA Market Cap History AY Market Cap History AZRE Market Cap History BABA Market Cap History BACA Market Cap History BAOS Market Cap History BAYA Market Cap History More Miscellaneous companies » |
AVDL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
